Methyl methacrylate

CASRN 80-62-6

Health Hazard Assessments for Effects Other than Cancer


Reference Dose for Oral Exposure (RfD) (PDF) (31 pp, 204 K) last updated: 03/02/1998

RfD (mg/kg-day) System Basis PoD Composite UF Confidence
1.4 None None NOAEL : 1.36 x102
mg/kg-day
100 Low/Medium

Reference Concentration for Inhalation Exposure (RfC) (PDF) (31 pp, 204 K) last updated: 03/02/1998

RfC (mg/m3) System Basis PoD Composite UF Confidence
7 x10-1 Nervous, Respiratory Degeneration/ atrophy of olfactory epithelium (male rats) BMC10 (HEC): 7.2
mg/m3
10 Medium/High

Cancer Assessment


Weight of Evidence for Cancer (PDF) (31 pp, 204 K) last updated: 03/02/1998

WOE Characterization Framework for WOE Characterization
E (Evidence of non-carcinogenicity for humans) Guidelines for Carcinogen Risk Assessment (US EPA, 1986)
Not likely to be carcinogenic to humans Proposed Guidelines for Carcinogen Risk Assessment (US EPA, 1996)
Basis:
  • Under EPA's 1986 Guidelines for Carcinogen Risk Assessment, MMA would be classified as evidence of non-carcinogenicity for humans or a Group E chemical. Under the Proposed Guidelines for Carcinogenic Risk Assessment (U.S. EPA, 1996), MMA is considered not likely to be carcinogenic to humans by any route of exposure because it has been evaluated in four well-conducted chronic inhalation studies in three appropriate animal species without demonstrating carcinogenic effects.
  • This may be a synopsis of the full weight-of-evidence narrative.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (31 pp, 204 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (31 pp, 204 K)

Not assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.